| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 673141 | Null | 0.00423163567577548 | 0.47481849 |
| NSC 67586 | 2-Naphthacenecarboxamide, N-[[(6,7-dihydro-7-oxo-1H-1,2,3-triazolo[4,5-d]pyrimidin-5-yl)amino]methyl]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, | 0.00423163567577548 | 0.19133345 |
| NSC 683086 | Boronic acid, [3-methyl-1-[[1-oxo-4-phenyl- 2-[[(2-quinolinyl)carbonyl]amino]butyl]amino]butyl]- | 0.00423163567577548 | 0.43772594 |
| NSC 684046 | Propanedithioamide, 2-[(4-aminocarbonyl-1H-imidazol-5-yl)hydrazono]-N-methyl- | 0.00423163567577548 | 0.28601693 |
| NSC 709440 | Null | 0.00423163567577548 | -0.10409804 |
| NSC 710716 | Null | 0.00423163567577548 | 0.59905174 |
| NSC 714604 | Purpureagitosid | 0.00423163567577548 | -0.051775768 |
| NSC 721049 | 7Z-Plakortide H | 0.00423163567577548 | 0.23908252 |
| NSC 730868 | (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one | 0.00423163567577548 | 0.38315945 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.00550789647802199 | 0.34577095 |